Andy ChenM.D., Ph.D.

  • Associate Professor of Medicine, Division of Hematology/Medical Oncology, School of Medicine


  • Cancer and Blood Disorders

Special focus on

  • Bone Marrow Transplant
  • Hematologic Malignancies
  • Lymphoma

I see patients at


Before scheduling your appointment, we recommend you contact your insurance company to verify that the OHSU Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any copayments, co–insurance, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with OHSU providers, your out of pocket liability may be higher. Visit the billing and insurance section of our site for more information.


Dr. Chen is a specialist in lymphoma and related malignancies. His research focuses on new treatments for lymphoma, and he has a particular interest in cellular immunotherapy such as chimeric antigen receptor T cell therapy (CAR-T). Dr. Chen attended Yale for college and then went to Harvard for his MD and PhD. He did his residency and fellowship training at Stanford before joining OHSU. He is past chair of the Patient Services Committee for the Leukemia & Lymphoma Society and is a member of national guideline and FDA advisory committees.


  • M.D., 2001, Harvard Medical School
  • Ph.D., 2001, Harvard University
  • Residency:

    • Internal medicine, Stanford University, 2004
  • Fellowship:

    • Hematology, medical oncology, and blood & marrow transplantation, Stanford University, 2008
  • Certifications:

    • Hematology, American Board of Internal Medicine
    • Medical Oncology, American Board of Internal Medicine


  • English

Memberships and associations

  • American Society of Hematology
  • American Society of Clinical Oncology
  • American Society of Blood and Marrow Transplantation

Patient ratings

4.8 out of 5 (96 Ratings, 25 Comments)

The patient ratings score is an average of all responses to the question "How likely would you be to recommend this provider to your family and friends (on a scale of 0 to 10)" on our nationally-recognized NRC patient surveys.

  1. {{ item.comments[0]['comment'] }}